Employees enter Sanofi-Aventis headquarters in Paris August 4, 2010. French drugmaker Sanofi-Aventis has made a $18.4 billion bid for Genzyme Corp, the U.S. biotech group, the equivalent of $69 per share. REUTERS/John
El Banco Sabadell hace 'tabula rasa' | Negocios | EL PAÍS
Banco Sabadell tiene 400 millones en hipotecas con clientes rusos y ucranianos